Učitavanje...
Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia
Since December 2019, a novel coronavirus pneumonia (COVID-19) has broken out in Wuhan, China and spread rapidly. Recent studies have found that ⁓ 15.7% of patients develop severe pneumonia, and cytokine storm is an important factor leading to rapid disease progression. Currently, there are no specif...
Spremljeno u:
| Izdano u: | Clin Drug Investig |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer International Publishing
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7183818/ https://ncbi.nlm.nih.gov/pubmed/32337664 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-020-00917-3 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|